DKL's distribution streak is not broken, but it has entered the one phase that matters most: the unit count is expanding faster than the proof of incremental cash generation. The August financing put 4.6 million new units into the market, while management's offset—up to $75 million of run-rate EBITDA from growth projects—remains a forward promise. That makes the 8.3% yield less of a free income signal and more of an execution wager. Our take is bearish: until project cash flow catches up, DKL is a prove-it story, and KNTK offers the cleaner operating-growth comparison.
The dilution math changed immediately. DKL priced 4.0 million common units at $50 and closed 4.6 million units after the underwriters exercised the full 600,000-unit option, raising about $220.8 million gross. Against the 19,688,283 units outstanding at June 30, the offering represents roughly a 23% increase in the unit base before the promised projects have produced their full economics. Delek US's ownership also fell from 63.0% to about 58.0%, making the ownership shift impossible to dismiss as a technical footnote. The proceeds will help repay revolver borrowings, but every new unit still competes for the same partnership distribution.
Management is asking investors to underwrite that dilution with future earning power. The 2026 growth capital program is expected to run $180 million to $190 million and generate up to $75 million of run-rate EBITDA. That could ultimately make the offering accretive, but up to $75 million is a prospective ceiling, not current cash flow. The timing matters: leverage stood at 4.23x at quarter-end and was up modestly from the first quarter. DKL is therefore funding expansion while asking the market to accept a larger denominator and waiting for the numerator to catch up.
The latest quarter showed progress, but not the broad-based operating acceleration needed to erase that concern. Second-quarter adjusted EBITDA rose to about $144 million from $127 million a year earlier, while DCF reached about $81 million. Yet wholesale marketing and terminaling EBITDA fell to $13 million from $23 million, and storage and transportation slipped to $16 million from $17 million. The growth is concentrated in gathering and processing and in projects still being built, rather than spread across the portfolio. The earnings record reinforces the execution risk: Q2 EPS came in at $0.54 versus a $1.12 estimate, and DKL has beaten estimates in only four of the last eight reported quarters.
Relative valuation does not give DKL much room to charge a premium for that uncertainty. DKL trades at 19.01 times trailing earnings and 2.42 times sales, while KNTK trades at 20.08 times earnings and 2.17 times sales. For that nearly comparable earnings multiple, KNTK brings 19.0% year-over-year revenue growth and a 25.3% net margin, versus DKL's 7.7% growth and 12.8% net margin. The TickerSpark Score lands at 68, with a strong Valuation sub-score of 75 but a much weaker Financial Health sub-score of 40; that split says the headline yield and valuation are doing more work than the balance sheet. Momentum is scored at 100, but momentum cannot distribute cash that new units have not yet helped generate.
There is a legitimate bullish version of this financing. DKL has about $1.1 billion of liquidity, and management refinanced debt with an $800 million senior note due in 2034 while retiring 2028 notes and partially redeeming 2029 notes. Using the offering proceeds to repay revolver borrowings could reduce near-term balance-sheet pressure, and a successful Libby Gas Complex and AGI buildout or faster water-business expansion could turn the $75 million EBITDA target into a real accretion story. The issue is not that the projects lack a possible payoff; it is that the payoff is still forward-looking while the dilution is already complete.
The income bulls also have evidence on their side. DKL raised its quarterly distribution to $1.135 per unit, or $4.54 annualized, extending a 54-quarter streak of increases. Five recent insider transactions were buys totaling 15,000 shares and $750,000, with no reported insider sells. The market is not treating the partnership as broken, and the 1.33x DCF coverage ratio remains above 1.0x. Still, the analyst consensus is Hold, with seven holds, two buys, and one sell, while DKL's year-to-date gain of 16.7% trails the energy sector's 40.7% advance. Strong insider buying and a rising payout support patience, not a free pass on per-unit growth.
That leaves DKL in the prove-it bucket rather than the core-income bucket. At $54.62, an 8.3% yield is attractive enough to keep the name on the watchlist, but not attractive enough to ignore a roughly 23% expansion in the unit base. We would not chase the distribution streak until the next results show that DCF is growing faster than the payout obligation and that the new capital is reducing, rather than merely refinancing, leverage pressure.
The next hard checkpoint is third-quarter 2026 reporting, likely around November 2026. What would change our mind is realized EBITDA from the growth projects, sustained DCF coverage after the offering, and clear evidence that revolver borrowings are falling. Until then, the $50 offering price is the fresh market reference point, and KNTK remains the better head-to-head choice for investors prioritizing operating growth: its 19.0% revenue growth and 25.3% net margin are stronger than DKL's 7.7% and 12.8% without demanding a meaningfully higher earnings multiple. DKL can earn back the benefit of the doubt, but the burden now sits with execution.
